Skip to main content
. 2021 Sep 3;8:712051. doi: 10.3389/fcvm.2021.712051

Table 3.

Implantation and follow-up results.

Standard group (n = 10) EAM guided group (n = 10) P -value
Successful HBP 9 (90.0%) 9 (90.0%) 1.00
Dual chamber pacemaker 10 (100.00%) 10 (100.00%) N/A
Procedural details*
    PT (min) 85.40 ± 22.34 86.50 ± 15.05 0.90
    Total FT (min) 12.36 ± 5.46 1.45 ± 0.58 <0.01
    HL-FT (min) 9.27 ± 5.44 0.84 ± 0.56 <0.01
    Total FD (mGy) 25.38 ± 11.15 3.13 ± 1.24 <0.01
    HL-FD (mGy) 19.06 ± 11.03 1.85 ± 1.17 <0.01
Paced QRSd (ms) 123.33 ± 20.10 120.89 ± 17.18 0.79
Pacing parameters
    Capture threshold (V/1 ms) 1.19 ± 0.35 1.10 ± 0.42 0.63
    R-wave amplitude (mV) 5.27 ± 2.30 5.23 ± 1.99 0.97
    Impedance (Ω) 576.67 ± 98.08 556.11 ± 98.67 0.66
Parameters at follow-up
    Capture threshold (V/1 ms) 1.29 ± 0.32 1.10 ± 0.29 0.21
    R-wave amplitude (mV) 5.51 ± 2.84 5.53 ± 2.03 0.93
    Impedance (Ω) 489.44 ± 67.77 479.22 ± 72.91 0.76
Echocardiography at follow-up
    LVEF (%) 62.00 ± 4.85 60.22 ± 4.41 0.30
LVEDD (mm) 51.11 ± 6.35 49.67 ± 3.12 0.55

EAM, electroanatomical mapping; FD, fluoroscopic dose; FT, fluoroscopic time; HBP, His bundle pacing; HL-FD, His lead fluoroscopic dose; HL-FT, His lead fluoroscopic time; PT, procedural time; QRSd, QRS duration; LVEDD, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction.

*

Including patients who failed to achieve HBP.